The German diagnostics company Definiens AG has raised €15 million from a syndicate co-led by Wellington Partners in order to support development of new tissue-based diagnostic tests for oncology and immunotherapy. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
